Hill-Rom Holdings, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Hill-Rom Holdings, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Hill-Rom Holdings, Inc. has recorded 41 public disclosures. The latest transaction was reported on 15 December 2021 (Disposition). Among the most active insiders: Ladone Mary Kay. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 December 2021
All Executives41 Thresholds0 Prospectus0 Other0
Declarations 41 total
● SVP, Pres. Front Line Care · Executives · 13 Dec 2021
16,539 shares Common Stock SEC:0001214659-21-013226:0
● SVP, Corp. Dev., Strat. & IR · Executives · 13 Dec 2021
2,284 shares Common Stock SEC:0001214659-21-013222:0
● President - Surgical Solutions · Executives · 13 Dec 2021
3,903.066 shares Common Stock SEC:0001214659-21-013215:0
● Director · Executives · 13 Dec 2021
5,376 shares Common Stock SEC:0001214659-21-013221:0
● SVP & Pres. - PSS Acute Care · Executives · 13 Dec 2021
13,566 shares Common Stock SEC:0001214659-21-013213:0
● Director · Executives · 13 Dec 2021
300 shares Common Stock SEC:0001214659-21-013212:0
● Corporate Controller · Executives · 13 Dec 2021
5,692.577 shares Common Stock SEC:0001214659-21-013218:0
● SVP, Chief Legal Officer · Executives · 13 Dec 2021
26,527 shares Common Stock SEC:0001214659-21-013216:0
● SVP, Chief Financial Officer · Executives · 13 Dec 2021
14,039.759 shares Common Stock SEC:0001214659-21-013211:0
● Director · Executives · 13 Dec 2021
2,000 shares Common Stock SEC:0001214659-21-013224:0
● Chief Executive Officer · Executives · 13 Dec 2021
34,870 shares Common Stock SEC:0001214659-21-013225:0
● SVP, Pres. Front Line Care · Executives · 24 Nov 2021
5,300 shares 0Common Stock SEC:0001214659-21-012903:0
◇ SVP, Chief Financial Officer · Executives · 6 Dec 2021
992 shares Common Stock SEC:0001214659-21-012902:0
● Chief Executive Officer · Executives · 10 Nov 2021
16,895 shares 0Common Stock SEC:0001214659-21-011984:0
◇ Corporate Controller · Executives · 12 Nov 2021
840 shares Common Stock SEC:0001214659-21-011925:0
◇ SVP, Pres. Front Line Care · Executives · 12 Nov 2021
1,115 shares Common Stock SEC:0001214659-21-011927:0
◇ President - Surgical Solutions · Executives · 12 Nov 2021
825 shares Common Stock SEC:0001214659-21-011924:0
◇ SVP, Chief Financial Officer · Executives · 12 Nov 2021
1,557 shares Common Stock SEC:0001214659-21-011929:0
◇ SVP, Corp. Dev., Strat. & IR · Executives · 12 Nov 2021
700 shares Common Stock SEC:0001214659-21-011930:0
◇ SVP & Pres. - PSS Acute Care · Executives · 12 Nov 2021
1,634 shares Common Stock SEC:0001214659-21-011928:0
◇ Chief Executive Officer · Executives · 12 Nov 2021
5,193 shares Common Stock SEC:0001214659-21-011933:0
◇ SVP, Chief Legal Officer · Executives · 12 Nov 2021
1,109 shares Common Stock SEC:0001214659-21-011926:0
◇ SVP, Corp. Dev., Strat. & IR · Executives · 11 Nov 2021
2,018 shares @ US$94.14 7.2% of flow Common Stock SEC:0001214659-21-011621:0
◇ SVP, Corp. Dev., Strat. & IR · Executives · 8 Nov 2021
872 shares @ US$78.16 2.6% of flow Common Stock SEC:0001214659-21-011441:0
◇ SVP, Pres. Front Line Care · Executives · 8 Nov 2021
644 shares Common Stock SEC:0001214659-21-011439:0
25 of 41 declarations
Load more (16 remaining) 关于 Hill-Rom Holdings, Inc. Hill-Rom Holdings, Inc. 是一家总部位于美国的医疗技术公司,曾在纽约证券交易所上市,股票代码为 HRC。该公司于 1969 年在印第安纳州注册成立,总部位于美国伊利诺伊州芝加哥。从历史上看,Hill-Rom 通过提供医院设备和互联护理解决方案,服务于急症护理医院、急性后期护理机构和家庭护理环境,建立了声誉。其品牌尤其与医院病床、治疗性支撑表面、跌倒和压力损伤预防系统、持续患者监测、呼吸护理设备以及相关临床工作流程解决方案相关联。([sec.gov](https://www.sec.gov/Archives/edgar/data/47518/000004751817000130/a2017q410k.htm?utm_source=openai))
从商业模式的角度来看,Hill-Rom 围绕患者支持、一线护理和呼吸/家庭护理疗法,运营着互补的产品和服务线。这种组合使公司既涉足资本设备,也涉足经常性的临床需求。其竞争地位得益于已建立的装机量、与医疗保健提供商的长期客户关系,以及对旨在提高患者安全性、更早发现病情恶化和减少临床环境中可避免并发症的技术的强烈关注。([hillrom.com](https://www.hillrom.com/en/products/centrella-smart-bed/?utm_source=openai))
从地理上看,Hill-Rom 在美国拥有重要的业务足迹,并在国际上开展业务。在其 2020 年提交给 SEC 的文件中,该公司报告全球约有 10,000 名员工,其中约 6,000 名在美国,约 4,000 名在美国以外,这突显了它是一家以国内为基础、具有全球影响力的公司。([sec.gov](https://www.sec.gov/Archives/edgar/data/47518/000004751820000129/hrc-20200930.htm?utm_source=openai))
最近最重要的进展是 Baxter International 收购了 Hillrom。Baxter 于 2021 年 9 月宣布了这项交易,并于 2021 年 12 月 13 日完成。Baxter 将此交易描述为扩大互联护理能力、拓宽医院、家庭和替代场所连续体中的访问权限,以及加速创新和国际扩张的一种方式。因此,Hill-Rom 不再作为一家独立的上市公司存在,因此历史上的 SEC 文件(包括内部人 Form 4 交易)应在此背景下解读。对于投资者而言,这意味着 Hill-Rom 最好被视为一个现已融入 Baxter 的传统医疗技术特许经营权,而不是一个活跃的独立上市公司。([baxter.com](https://www.baxter.com/baxter-newsroom/baxter-acquire-hillrom-expanding-connected-care-and-medical-innovation-globally?utm_source=openai))